Skip to main content

Advertisement

SpringerLink
Log in

Is cholesterol a mediator of cold-induced cancer?

  • Original Article
  • Published:
Tumor Biology

Abstract

Many factors such as smoking, obesity, and high fat have been either directly or indirectly linked to cancer deaths and/or incidences. Similarly, abnormal serum cholesterol levels have been assigned as a risk factor for cancer, but some studies show a discrepant result. To resolve this discrepancy, we have analyzed cholesterol data of 166 countries. Univariate analysis showed a positive correlation between serum average total cholesterol (ATC) and overall cancer mortality rate (CMR) [tau = 0.277, z = 5.19, p < 0.0001]. It was also observed that a similar positive correlation was found between ATC and different anatomical site-specific CMRs in lung, bladder, ovarian, breast, and pancreatic cancers. Our recent published data documented an existence of a negative correlation between average annual temperature (AAT) and overall CMR, as well as CMR of the abovementioned anatomical site-specific cancers. Statistical analysis further shows a negative correlation between AAT and ATC, similar to that of AAT and CMR. The resulting patterns of univariate analysis between AAT and CMR are almost identical with AAT and ATC, when this analysis was performed every 2 °C of AAT increment for all countries. Moreover, geographical location of the top 50 countries having the highest CMR is almost similar to the top 50 countries having the highest ATC. Similarly, the least 50 countries having the lowest CMR are located in the same geographical region, similar to the least 50 countries having the lowest ATC. These data along with other literature reports suggest that cholesterol could be a mediator of cold-induced cancer mortality.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9

Similar content being viewed by others

References

  1. McGranahan N, Swanton C. Biological and therapeutic impact of intratumor heterogeneity in cancer evolution. Cancer Cell. 2015;27(1):15–26.

    Article  CAS  PubMed  Google Scholar 

  2. Bhowmick NA, Neilson EG, Moses HL. Stromal fibroblasts in cancer initiation and progression. Nature. 2004;432(7015):332–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Kalluri R, Zeisberg M. Fibroblasts in cancer. Nat Rev Cancer. 2006;6(5):392–401.

    Article  CAS  PubMed  Google Scholar 

  4. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646–74.

    Article  CAS  PubMed  Google Scholar 

  5. Qian B-Z, Pollard JW. Macrophage diversity enhances tumor progression and metastasis. Cell. 2010;141(1):39–51.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. de Visser KE, Eichten A, Coussens LM. Paradoxical roles of the immune system during cancer development. Nat Rev Cancer. 2006;6(1):24–37.

    Article  PubMed  Google Scholar 

  7. Sieber OM, Heinimann K, Tomlinson IP. Genomic instability—the engine of tumorigenesis? Nat Rev Cancer. 2003;3(9):701–8.

    Article  CAS  PubMed  Google Scholar 

  8. Jones PA, Baylin SB. The epigenomics of cancer. Cell. 2007;128(4):683–92.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Sharma S, Kelly TK, Jones PA. Epigenetics in cancer. Carcinogenesis. 2010;31(1):27–36.

    Article  CAS  PubMed  Google Scholar 

  10. Tam WL, Weinberg RA. The epigenetics of epithelial-mesenchymal plasticity in cancer. Nat Med. 2013;19(11):1438–49.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. You JS, Jones PA. Cancer genetics and epigenetics: two sides of the same coin? Cancer Cell. 2012;22(1):9–20.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Orimo A, Weinberg RA. Stromal fibroblasts in cancer: a novel tumor-promoting cell type. Cell Cycle. 2006;5(15):1597–601.

    Article  CAS  PubMed  Google Scholar 

  13. Lee H-W, Choi H-J, Ha S-J, Lee K-T, Kwon Y-G. Recruitment of monocytes/macrophages in different tumor microenvironments. Biochimica et Biophysica Acta (BBA)-Rev Cancer. 2013;1835(2):170–9.

    Article  CAS  Google Scholar 

  14. Condeelis J, Pollard JW. Macrophages: obligate partners for tumor cell migration, invasion, and metastasis. Cell. 2006;124(2):263–6.

    Article  CAS  PubMed  Google Scholar 

  15. Joyce JA. Therapeutic targeting of the tumor microenvironment. Cancer Cell. 2005;7(6):513–20.

    Article  CAS  PubMed  Google Scholar 

  16. Whiteside T. The tumor microenvironment and its role in promoting tumor growth. Oncogene. 2008;27(45):5904–12.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Minamoto T, Mai M, Ronai ZE. Environmental factors as regulators and effectors of multistep carcinogenesis. Carcinogenesis. 1999;20(4):519–27.

    Article  CAS  PubMed  Google Scholar 

  18. Mathers JC, Strathdee G, Relton CL. Induction of epigenetic alterations by dietary and other environmental factors. Adv Genet. 2010;71:3.

    PubMed  Google Scholar 

  19. Herceg Z, Paliwal A. Epigenetic mechanisms in hepatocellular carcinoma: how environmental factors influence the epigenome. Mutat Res Rev Mutat Res. 2011;727(3):55–61.

    Article  CAS  Google Scholar 

  20. Rønnov-Jessen L, Bissell MJ. Breast cancer by proxy: can the microenvironment be both the cause and consequence? Trends Mol Med. 2009;15(1):5–13.

    Article  PubMed  Google Scholar 

  21. Sasco A, Secretan M, Straif K. Tobacco smoking and cancer: a brief review of recent epidemiological evidence. Lung Cancer. 2004;45:S3–9.

    Article  PubMed  Google Scholar 

  22. Freedman LS, Clifford C, Messina M. Analysis of dietary fat, calories, body weight, and the development of mammary tumors in rats and mice: a review. Cancer Res. 1990;50(18):5710–9.

    CAS  PubMed  Google Scholar 

  23. Lehrer S, Rosenzweig KE. Cold climate is a risk factor for thyroid cancer. Clinical Thyroidology. 2014;26(10):273–6.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Calle EE, Kaaks R. Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer. 2004;4(8):579–91.

    Article  CAS  PubMed  Google Scholar 

  25. Giovannucci E, Harlan DM, Archer MC, Bergenstal RM, Gapstur SM, Habel LA, et al. Diabetes and cancer: a consensus report. CA Cancer J Clin. 2010;60(4):207–21.

    Article  PubMed  Google Scholar 

  26. Kiberstis PA. Cholesterol and cancer. Sci Signal. 2013;6(304):ec292-ec.

    Article  Google Scholar 

  27. Mandal C. Targeting intracellular cholesterol is a novel therapeutic strategy for cancer treatment. J Cancer Sci Ther. 2014;6.

  28. Mandal CC. High cholesterol deteriorates bone health: new insights into molecular mechanisms. Front Endocrinol. 2015;6

  29. Sharma A, Verma HK, Joshi S, Panwar MS, Mandal CC. A link between cold environment and cancer. Tumor Biol. 2015:1-12.

  30. Kokolus KM, Capitano ML, Lee C-T, Eng JW-L, Waight JD, Hylander BL, et al. Baseline tumor growth and immune control in laboratory mice are significantly influenced by subthermoneutral housing temperature. Proc Natl Acad Sci. 2013;110(50):20176–81.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Du G, Zhao B, Zhang Y, Sun T, Liu W, Li J, et al. Hypothermia activates adipose tissue to promote malignant lung cancer progression. PLoS One. 2013;8(8):e72044.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Eng JWL, Reed CB, Kokolus KM, Pitoniak R, Utley A, Bucsek MJ et al. Housing temperature-induced stress drives therapeutic resistance in murine tumour models through β2-adrenergic receptor activation. Nat Commun. 2015;6. doi:10.1038/ncomms7426.

  33. Nelson KE, Kmush B, Labrique AB. The epidemiology of hepatitis E virus infections in developed countries and among immunocompromised patients. Expert Rev Anti Infect Ther. 2011;9(12):1133–48.

    Article  PubMed  Google Scholar 

  34. Forman D, de Martel C, Lacey CJ, Soerjomataram I, Lortet-Tieulent J, Bruni L, et al. Global burden of human papillomavirus and related diseases. Vaccine. 2012;30:F12–23.

    Article  PubMed  Google Scholar 

  35. Hunt R, Xiao S, Megraud F, Leon-Barua R, Bazzoli F, Van der Merwe S, et al. Helicobacter pylori in developing countries. World Gastroenterology Organisation global guideline. J Gastrointestin Liver Dis. 2011;20(3):299–304.

    CAS  PubMed  Google Scholar 

  36. Ravnskov U. High cholesterol may protect against infections and atherosclerosis. QJM. 2003;96(12):927–34.

    Article  CAS  PubMed  Google Scholar 

  37. Wunder C, Churin Y, Winau F, Warnecke D, Vieth M, Lindner B, et al. Cholesterol glucosylation promotes immune evasion by Helicobacter pylori. Nat Med. 2006;12(9):1030–8.

    Article  CAS  PubMed  Google Scholar 

  38. Mattock M, Caunce M. Cold-induced increases in erythrocyte count, plasma cholesterol and plasma fibrinogen of elderly people without a comparable rise in protein C or factor X. Clin Sci. 1994;86:43–8.

    Article  PubMed  Google Scholar 

  39. Ravussin Y, Xiao C, Gavrilova O, Reitman ML. Effect of intermittent cold exposure on brown fat activation, obesity, and energy homeostasis in mice. PLoS One. 2014;9(1):e85876.

    Article  PubMed  PubMed Central  Google Scholar 

  40. Dong M, Yang X, Lim S, Cao Z, Honek J, Lu H, et al. Cold exposure promotes atherosclerotic plaque growth and instability via UCP1-dependent lipolysis. Cell Metab. 2013;18(1):118–29.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  41. Gordon DJ, Hyde J, Trost DC, Whaley FS, Hannan PJ, Jacobs DR, et al. Cyclic seasonal variation in plasma lipid and lipoprotein levels: the lipid research clinics coronary primary prevention trial placebo group. J Clin Epidemiol. 1988;41(7):679–89.

    Article  CAS  PubMed  Google Scholar 

  42. Ockene IS, Chiriboga DE, Stanek III EJ, Harmatz MG, Nicolosi R, Saperia G, et al. Seasonal variation in serum cholesterol levels: treatment implications and possible mechanisms. Arch Intern Med. 2004;164(8):863–70.

    Article  CAS  PubMed  Google Scholar 

  43. Chen H, Qin S, Wang M, Zhang T, Zhang S. Association between cholesterol intake and pancreatic cancer risk: evidence from a meta-analysis. Sci Rep. 2015;5:8243.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  44. Hu J, La Vecchia C, De Groh M, Negri E, Morrison H, Mery L. Dietary cholesterol intake and cancer. Ann Oncol. 2012;23(2):491–500.

    Article  CAS  PubMed  Google Scholar 

  45. Kimura Y, Sumiyoshi M. High-fat, high-sucrose, and high-cholesterol diets accelerate tumor growth and metastasis in tumor-bearing mice. Nutr Cancer. 2007;59(2):207–16.

    Article  CAS  PubMed  Google Scholar 

  46. McDonnell D, Chang C-Y, Nelson E. The estrogen receptor as a mediator of the pathological actions of cholesterol in breast cancer. Climacteric. 2014;17(S2):60–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  47. dos Santos CR, Fonseca I, Dias S, de Almeida JM. Plasma level of LDL-cholesterol at diagnosis is a predictor factor of breast tumor progression. BMC Cancer. 2014;14(1):132.

    Article  Google Scholar 

  48. Wirehn AB, Tornberg S, Carstensen J. Serum cholesterol and testicular cancer incidence in 45,000 men followed for 25 years. Br J Cancer. 2005;92(9):1785–6.

    Article  PubMed  PubMed Central  Google Scholar 

  49. Morote J, Celma A, Planas J, Placer J, de Torres I, Olivan M, et al. Role of serum cholesterol and statin use in the risk of prostate cancer detection and tumor aggressiveness. Int J Mol Sci. 2014;15(8):13615–23.

    Article  PubMed  PubMed Central  Google Scholar 

  50. Pelton K, Freeman MR, Solomon KR. Cholesterol and prostate cancer. Curr Opin Pharmacol. 2012;12(6):751–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  51. Mondul AM, Weinstein SJ, Virtamo J, Albanes D. Serum total and HDL cholesterol and risk of prostate cancer. Cancer Causes Control. 2011;22(11):1545–52.

    Article  PubMed  PubMed Central  Google Scholar 

  52. Melvin JC, Seth D, Holmberg L, Garmo H, Hammar N, Jungner I, et al. Lipid profiles and risk of breast and ovarian cancer in the Swedish AMORIS study. Cancer Epidemiol Biomark Prev. 2012;21(8):1381–4.

    Article  CAS  Google Scholar 

  53. Lindemann K, Vatten LJ, Ellstrøm‐Engh M, Eskild A. Serum lipids and endometrial cancer risk: results from the HUNT‐II study. Int J Cancer. 2009;124(12):2938–41.

    Article  CAS  PubMed  Google Scholar 

  54. Kritchevsky SB, Kritchevsky D. Serum cholesterol and cancer risk: an epidemiologic perspective. Annu Rev Nutr. 1992;12(1):391–416.

    Article  CAS  PubMed  Google Scholar 

  55. Cambien F, Ducimetiere P, Richard J. Total serum cholesterol and cancer mortality in a middle-aged male population. Am J Epidemiol. 1980;112(3):388–94.

    Article  CAS  PubMed  Google Scholar 

  56. Nago N, Ishikawa S, Goto T, Kayaba K. Low cholesterol is associated with mortality from stroke, heart disease, and cancer: the Jichi Medical School cohort study. J Epidemiol. 2011;21(1):67–74.

    Article  PubMed  PubMed Central  Google Scholar 

  57. Knekt P, Reunanen A, Aromaa A, Heliövaara M, Hakulinen T, Hakama M. Serum cholesterol and risk of cancer in a cohort of 39,000 men and women. J Clin Epidemiol. 1988;41(6):519–30.

    Article  CAS  PubMed  Google Scholar 

  58. Kitahara CM, de González AB, Freedman ND, Huxley R, Mok Y, Jee SH, et al. Total cholesterol and cancer risk in a large prospective study in Korea. J Clin Oncol. 2011;29(12):1592–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  59. Nielsen SF, Nordestgaard BG, Bojesen SE. Statin use and reduced cancer-related mortality. N Engl J Med. 2012;367(19):1792–802. doi:10.1056/NEJMoa1201735.

    Article  CAS  PubMed  Google Scholar 

  60. Neil A, Cooper J, Betteridge J, Capps N, McDowell I, Durrington P, et al. Reductions in all-cause, cancer, and coronary mortality in statin-treated patients with heterozygous familial hypercholesterolaemia: a prospective registry study. Eur Heart J. 2008;29(21):2625–33.

    Article  PubMed  PubMed Central  Google Scholar 

  61. Mandal CC, Ghosh-Choudhury N, Yoneda T, Choudhury GG. Simvastatin prevents skeletal metastasis of breast cancer by an antagonistic interplay between p53 and CD44. J Biol Chem. 2011;286(13):11314–27. doi:10.1074/jbc.M110.193714.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  62. Ghosh-Choudhury N, Mandal CC, Ghosh-Choudhuryz G. Simvastatin induces derepression of PTEN expression via NFkappaB to inhibit breast cancer cell growth. Cell Signal. 2010;22(5):749–58. doi:10.1016/j.cellsig.2009.12.010.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  63. Park YH, Jung HH, Ahn JS, Im YH. Statin induces inhibition of triple negative breast cancer (TNBC) cells via PI3K pathway. Biochem Biophys Res Commun. 2013;439(2):275–9.

    Article  CAS  PubMed  Google Scholar 

  64. Bababeygy SR, Polevaya NV, Youssef S, Sun A, Xiong A, Prugpichailers T, et al. HMG-CoA reductase inhibition causes increased necrosis and apoptosis in an in vivo mouse glioblastoma multiforme model. Anticancer Res. 2009;29(12):4901–8.

    CAS  PubMed  Google Scholar 

  65. Liu H, Wang Z, Li Y, Li W, Chen Y. Simvastatin prevents proliferation and bone metastases of lung adenocarcinoma in vitro and in vivo. Neoplasma. 2013;60(3):240–6.

    Article  CAS  PubMed  Google Scholar 

  66. Khurana V, Caldito G, Ankem M. Statins might reduce risk of renal cell carcinoma in humans: case-control study of 500,000 veterans. Urology. 2008;71(1):118–22. doi:10.1016/j.urology.2007.08.039.

    Article  PubMed  Google Scholar 

  67. Singh PP, Singh S. Statins and risk reduction in hepatocellular carcinoma: fact or fiction? J Clin Oncol. 2012;30(20):2569–70. doi:10.1200/JCO.2012.43.2179.

    Article  PubMed  Google Scholar 

  68. Singh S, Singh PP, Singh AG, Murad MH, Sanchez W. Statins are associated with a reduced risk of hepatocellular cancer: a systematic review and meta-analysis. Gastroenterology. 2013;144(2):323–32. doi:10.1053/j.gastro.2012.10.005.

    Article  CAS  PubMed  Google Scholar 

  69. Kuoppala J, Lamminpaa A, Pukkala E. Statins and cancer: a systematic review and meta-analysis. Eur J Cancer. 2008;44(15):2122–32. doi:10.1016/j.ejca.2008.06.025.

    Article  CAS  PubMed  Google Scholar 

  70. Sacks FM, Pfeffer MA, Moye LA, Rouleau JL, Rutherford JD, Cole TG, et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators. N Engl J Med. 1996;335(14):1001–9. doi:10.1056/NEJM199610033351401.

    Article  CAS  PubMed  Google Scholar 

  71. Dawwas MF. Statin use and reduced cancer-related mortality. N Engl J Med. 2013;368(6):574–5. doi:10.1056/NEJMc1214827#SA2.

    Article  PubMed  Google Scholar 

  72. Klop C, Driessen JH, de Vries F. Statin use and reduced cancer-related mortality. N Engl J Med. 2013;368(6):574. doi:10.1056/NEJMc1214827#SA1.

    Article  PubMed  Google Scholar 

  73. Zhong S, Zhang X, Chen L, Ma T, Tang J, Zhao J. Statin use and mortality in cancer patients: systematic review and meta-analysis of observational studies. Cancer Treat Rev. 2015;41(6):554–67.

    Article  CAS  PubMed  Google Scholar 

  74. Martin BJ, van Golen KL. A comparison of cholesterol uptake and storage in inflammatory and noninflammatory breast cancer cells. Int J Breast Cancer. 2012;2012:412581. doi:10.1155/2012/412581.

    Article  PubMed  PubMed Central  Google Scholar 

  75. Smith B, Land H. Anticancer activity of the cholesterol exporter ABCA1 gene. Cell Rep. 2012;2(3):580–90. doi:10.1016/j.celrep.2012.08.011.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  76. Dessi S, Batetta B, Pulisci D, Spano O, Anchisi C, Tessitore L, et al. Cholesterol content in tumor tissues is inversely associated with high-density lipoprotein cholesterol in serum in patients with gastrointestinal cancer. Cancer. 1994;73(2):253–8.

    Article  CAS  PubMed  Google Scholar 

  77. Freeman MR, Solomon KR. Cholesterol and prostate cancer. J Cell Biochem. 2004;91(1):54–69. doi:10.1002/jcb.10724.

    Article  CAS  PubMed  Google Scholar 

  78. Llaverias G, Danilo C, Mercier I, Daumer K, Capozza F, Williams TM, et al. Role of cholesterol in the development and progression of breast cancer. Am J Pathol. 2011;178(1):402–12. doi:10.1016/j.ajpath.2010.11.005.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  79. Notarnicola M, Messa C, Pricci M, Guerra V, Altomare DF, Montemurro S, et al. Up-regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity in left-sided human colon cancer. Anticancer Res. 2004;24(6):3837–42.

    CAS  PubMed  Google Scholar 

  80. Eberlin LS, Dill AL, Costa AB, Ifa DR, Cheng L, Masterson T, et al. Cholesterol sulfate imaging in human prostate cancer tissue by desorption electrospray ionization mass spectrometry. Anal Chem. 2010;82(9):3430–4.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  81. Hart J. Association between air temperature and cancer death rates in Florida: an ecological study. Dose-Response. 2014;1(1):1–10.

    Google Scholar 

  82. Shi L, Fei X, Sun G, Wang Z, Wan Y, Zeng Y et al. Hypothermia stimulates glioma stem spheres to spontaneously dedifferentiate adjacent non-stem glioma cells. Cell Mol Neurobiol. 2014:1-14.

Download references

Acknowledgments

Authors thank to Smita Majumder (Department of Mathematics, Central University of Rajasthan, India) for her support in data collection and statistical analysis. CCM is supported by UGC [30-49/2014 (BSR)], DBT [6242-P9/RGCB/PMD/DBT/CCML/2015], and Central University of Rajasthan, India.

Author information

Authors and Affiliations

  1. Department of Biochemistry, Central University of Rajasthan, NH-8, Bandarsindri, Kishangarh, 305817, Ajmer, Rajasthan, India

    Chandi C. Mandal & Ankit Sharma

  2. Department of Statistics, Central University of Rajasthan, 305817, Ajmer, Rajasthan, India

    Mahaveer S. Panwar

  3. Department of Oral Medicine and Diagnostic Sciences, College of Dentistry, University of Illinois at Chicago, Chicago, IL, 60612, USA

    James A. Radosevich

Authors
  1. Chandi C. Mandal
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ankit Sharma
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mahaveer S. Panwar
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. James A. Radosevich
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Chandi C. Mandal.

Ethics declarations

Conflicts of interest

None

Electronic supplementary material

Below is the link to the electronic supplementary material.

Table S1

(PDF 291 kb)

Table S2

(PDF 284 kb)

Table S3

(PDF 209 kb)

Table S4

(PDF 224 kb)

Table S5

(PDF 288 kb)

Fig. S1

(PDF 162 kb)

Fig. S2

(PDF 204 kb)

Fig. S3

(PDF 153 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Mandal, C.C., Sharma, A., Panwar, M.S. et al. Is cholesterol a mediator of cold-induced cancer?. Tumor Biol. 37, 9635–9648 (2016). https://doi.org/10.1007/s13277-016-4799-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13277-016-4799-2

Keywords

Search

Navigation